TTRX
Turn Therapeutics Inc.
12.40$
-7.3%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 24 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | |
| – | – | – | +3.5% | +2.1% | +0.6% | – | |
| – | – | – | – | – | – | – | |
| – | -15.3% | +153.2% | -78.0% | +213.3% | +334.1% | – | |
| – | +355.6% | +34.6% | +23.0% | -47.3% | +1.4% | – | |
| – | +279.4% | +39.0% | +14.7% | -43.5% | +31.0% | – | |
| – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | |
| – | – | – | – | -447.9% | – | – | |
| – | – | – | – | -447.9% | – | – | |
| – | – | – | – | -426.2% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.